Ranbaxy Drug Patent Portfolio
Ranbaxy owns 1 orange book drug protected by 1 US patent Given below is the list of Ranbaxy's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6890957 | Liquid formulation of metformin | 14 Sep, 2023 | Expired |
Latest Legal Activities on Ranbaxy's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ranbaxy.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 25 May, 2007 | US6890957 |
| Petition Entered | 29 Jan, 2007 | US6890957 |
| Post Issue Communication - Certificate of Correction Denied | 14 Dec, 2006 | US6890957 |
| Post Issue Communication - Certificate of Correction | 17 Aug, 2005 | US6890957 |
|
Recordation of Patent Grant Mailed
Critical
| 10 May, 2005 | US6890957 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 10 May, 2005 | US6890957 |
|
Issue Notification Mailed
Critical
| 20 Apr, 2005 | US6890957 |
| Receipt into Pubs | 14 Apr, 2005 | US6890957 |
| Dispatch to FDC | 13 Apr, 2005 | US6890957 |
|
Application Is Considered Ready for Issue
Critical
| 13 Apr, 2005 | US6890957 |
| Receipt into Pubs | 12 Apr, 2005 | US6890957 |
|
Issue Fee Payment Verified
Critical
| 04 Apr, 2005 | US6890957 |
|
Issue Fee Payment Received
Critical
| 04 Apr, 2005 | US6890957 |
| Workflow - File Sent to Contractor | 24 Jan, 2005 | US6890957 |
|
Mail Notice of Allowance
Critical
| 06 Jan, 2005 | US6890957 |
Ranbaxy's Family Patents
Recent FDA approvals and tentative approvals for Ranbaxy
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Galantamine Hydrobromide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 28 Aug, 2007 |
| Fexofenadine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 16 May, 2007 |
| Sertraline Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 30 Nov, 2006 |
Ranbaxy Drug List
Given below is the complete list of Ranbaxy's drugs and the patents protecting them.
1. Riomet
Riomet is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6890957 | Liquid formulation of metformin |
14 Sep, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Riomet's drug page